Johannesburg, South Africa – Brunel Laboratoria (Pty) Ltd has announced the
commencement of the operational integration of Avid Brands S.A. into the business.
The merger brings together two established South African businesses with
complementary strengths across healthcare and personal care, creating a combined
business with 37 established brands.

While the merger was completed at shareholder level in November 2025. The
integration will combine the capabilities, expertise and established relationships of
both organisations under the Brunel Laboratoria name.

The joined capabilities create opportunities to strengthen the business across both
pharmacy and retail channels, while enabling greater focus on distribution, customer
relationships and product development.

Brunel Laboratoria will bring together a larger commercial operation, with more
salespeople operating in the field, supported by dedicated retail and pharmacy
leadership. The expanded team will allow Brunel Laboratoria to increase its focus on
pharmacy relationships while strengthening its engagement with major retail and trade
customers.

“This merger brings together two South African businesses with diverse strengths and a
shared opportunity for growth,” said Michiel Venter, Chief Executive Officer of Brunel
Laboratoria.

“Brunel Laboratoria has built strong capabilities in pharmacy and distribution, while
Avid has developed strong retail relationships and a portfolio of established brands.
Bringing these strengths together creates a more capable business, with the scale and
resources to serve our customers and partners more effectively.”

“Having been part of Avid since 2004, I have seen the business and its brands develop
over more than two decades. Bringing our teams, relationships and expertise together
with Brunel Laboratoria creates an exciting opportunity to build on that history while
creating something stronger for our customers and the market,” said Deon Verster,
Sales Director of Brunel Laboratoria.

The operational integration will bring Avid’s teams and capabilities into the broader
Brunel Laboratoria organisation, including sales, marketing, supply chain, warehouse
and sales support functions. The combined management structure will bring together
combined expertise across commercial, operational, financial and people functions.
The combined business will be headquartered in Gauteng, with a satellite office in
Durban to support the company’s national operations.

For existing customers and partners, the focus remains on maintaining continuity while
strengthening the capabilities supporting them. Brunel Laboratoria will continue to
invest in its brands, relationships and overall capabilities to support consistent product
availability and create opportunities for continued innovation and growth.

The merger represents an important milestone in Brunel Laboratoria’s development,
bringing together two established South African businesses to create a stronger
platform for growth across the country’s healthcare and personal-care markets.